Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Myeloproliferative Neoplasms
1 article
New Hope for Myelofibrosis: Low-Dose Decitabine Shows Promise in Phase 2 Trial
Phase 2 trial reveals potential of low-dose subcutaneous decitabine for treating myelofibrosis cytopenias.